Moderna’s vaccine candidate was found to be 94.5% effective in clinical trials, the company announced last week.

The development process was unprecedentedly fast — only the team of Pfizer and BioNTech beat the newcomer in announcing results from a late-stage clinical trial.

It was also far more effective than expected: The Food and Drug Administration had said it would likely approve a candidate that showed at least 50% efficacy. Dr. Anthony Fauci had said he hoped for 70%.

Sins of Omission

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: